Abstract:Objective The Endocrine Society recommends a postpartum fasting blood glucose (FBG) be performed for patients with gestational diabetes mellitus (GDM) prior to hospital discharge to screen for ongoing hyperglycemia. There are limited data, however, on whether an FBG can screen for glucose intolerance and if it correlates with the gold standard 4- to 12-week 2-hour oral glucose tolerance test (OGTT). Our objective was to evaluate if FBG correlates with the gold standard 2-hour OGTT. Study Design This retrospective cohort study of patients with GDM who delivered >20 weeks' gestation at two urban centers from January 2017 to December 2020 included those who completed both a postpartum FBG prior to discharge and a 2-hour 75-g OGTT within 1 year of delivery. Abnormal 2-hour OGTT was defined as fasting value ≥100 mg/dL and/or 2-hour value ≥140 mg/dL. We evaluated test characteristics (e.g., sensitivity, specificity) of postpartum FBG cut-offs to predict an abnormal 2-hour OGTT result. Results A total of 235 patients met inclusion criteria, of which 63% were diet-controlled and 37% required medical management. FBG ranged from 64 to 134 mg/dL, with 6/235 (2.6%) with values ≥126 mg/dL. A total of 39/235 (16.6%) of patients had an abnormal 2-hour OGTT. Overall, area under the curve for FBG predicting abnormal 2-hour OGTT was 0.65. Traditionally considered high cut-offs (≥126 mg/dL) for predicting persistent impaired glucose intolerance demonstrated poor positive predictive value (PPV; 90%). A postpartum FBG of 88 mg/dL was determined to be the optimal cut-off for FBG with NPV = 92.4% (Youden index = 0.34). In this dataset, if FBG ≥ 88 mg/dL was used to determine if 2-hour OGTT was required, almost half of GDM patients could avoid further glucose tolerance testing. Conclusion While previously thought of as best utilized for its PPV, the FBG may be best used for its NPV. In our study, clinical application of an FBG < 88 mg/dL was highly correlative with a normal 2-hour OGTT. Key Points Screening for postpartum glucose intolerance is essential for gestational diabetes. A promising initiative includes offering screening tests while in the hospital, including an FBG. Application of a postpartum FBG < 88 mg/dL is highly correlative with a normal 2-hour OGTT. Received: 03 July 2024 Accepted: 17 September 2024 Accepted Manuscript online: 17 September 2024 Article published online: 01 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment

179-LB: Should We Screen with a Fasting Blood Glucose Test? A Novel Two-Step Screening Strategy for Gestational Diabetes—A Large Tertiary Comparative Cohort Study

Insulin Resistance and Lipid Profile During an Oral Glucose Tolerance Test in Women with and Without Gestational Diabetes Mellitus

Gestational diabetes mellitus screening and diagnosis criteria before and during the COVID-19 pandemic: a retrospective pre-post study

Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus

Employing fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studies

Effects of implementing a routine postpartum fasting blood glucose on the completion of the gold standard 2-hour oral glucose tolerance test in gestational diabetics

Fasting Glucose Level on the Oral Glucose Tolerance Test Is Associated with the Need for Pharmacotherapy in Gestational Diabetes Mellitus

Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus

Clinical utility of point‐of‐care glucose testing in the assessment of gestational diabetes: Prospective cohort study

Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus

Difference Between 2 H and 3 H 75 G Glucose Tolerance Test in the Diagnosis of Gestational Diabetes Mellitus (GDM): Results from a National Survey on Prevalence of GDM

Predictive Value of Early Pregnancy Fasting Blood Glucose for Development of Gestational Diabetes Mellitus

Performance of point-of-care glucose testing for the diagnosis of gestational diabetes in South Africa

Fasting blood glucose as a screening measure for late-onset gestational diabetes in the third trimester

A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study

Gestational diabetes mellitus – Can we do better with postpartum diabetes screening?

Assessment of the Optimal Cutoff Value of Fasting Plasma Glucose to Establish Diagnosis of Gestational Diabetes Mellitus in Chinese Women

Postpartum Glucose Monitoring in Pregnant Women with Gestational Diabetes Mellitus: A Dual Center Experience

Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention

High Fasting Plasma Glucose during Early Pregnancy: A Review about Early Gestational Diabetes Mellitus